Correlation Between 23Andme Holding and Elicio Therapeutics

Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and Elicio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and Elicio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between 23Andme Holding Co and Elicio Therapeutics, you can compare the effects of market volatilities on 23Andme Holding and Elicio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of Elicio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and Elicio Therapeutics.

Diversification Opportunities for 23Andme Holding and Elicio Therapeutics

-0.45

Correlation Coefficient

23Andme Holding  Elicio Therapeutics

Very good diversification

The 3 months correlation between 23Andme and Elicio is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and Elicio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elicio Therapeutics and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with Elicio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elicio Therapeutics has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and Elicio Therapeutics go up and down completely randomly.

Pair Corralation between 23Andme Holding and Elicio Therapeutics

Allowing for the 90-day total investment horizon 23Andme Holding is expected to generate 2.49 times less return on investment than Elicio Therapeutics. But when comparing it to its historical volatility, 23Andme Holding Co is 1.01 times less risky than Elicio Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Elicio Therapeutics is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  481.00  in Elicio Therapeutics on October 6, 2024 and sell it today you would earn a total of  81.00  from holding Elicio Therapeutics or generate 16.84% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

23Andme Holding Co  vs.  Elicio Therapeutics

23Andme Holding

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days 23Andme Holding Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Elicio Therapeutics

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Elicio Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Elicio Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with 23Andme Holding and Elicio Therapeutics

The main advantage of trading using opposite 23Andme Holding and Elicio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, Elicio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elicio Therapeutics will offset losses from the drop in Elicio Therapeutics' long position.

The idea behind 23Andme Holding Co and Elicio Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.